Article info
PDFRetina
Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
- Correspondence to Professor Hua Yan, Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China; zyyyanhua{at}tmu.edu.cn
Citation
Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
Publication history
- Received July 25, 2023
- Accepted November 5, 2023
- First published November 28, 2023.
Online issue publication
July 23, 2024
Article Versions
- Previous version (28 November 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.